MEDICALGRAPHICS.DEResearchers have edited the human genome before, but always in cells outside the body. Now, biotech company Sangamo Therapeutics is recruiting participants for clinical trials in which patients with hemophilia B, Hurler syndrome, or Hunter syndrome will have the gene...
Read full post here:
https://skpsoft.com/science/first-in-vivo-human-genome-editing-to-be-tested-in-new-clinical-trial/
Thursday, May 18, 2017
First In Vivo Human Genome Editing to Be Tested in New Clinical Trial
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment